Author
Listed:
- Zhenyue Hao
(The Campbell Family Institute for Breast Cancer Research, University Health Network
Princess Margaret Cancer Centre, University Health Network
University of Toronto
The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto)
- Yi Sheng
(York University)
- Gordon S. Duncan
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Wanda Y. Li
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Carmen Dominguez
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Jennifer Sylvester
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Yu-Wen Su
(The Campbell Family Institute for Breast Cancer Research, University Health Network
Immunology Research Center, National Health Research Institutes)
- Gloria H.Y. Lin
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Bryan E. Snow
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Dirk Brenner
(Experimental and Molecular Immunology, Luxembourg Institute of Health
Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark)
- Annick You-Ten
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Jillian Haight
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Satoshi Inoue
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Andrew Wakeham
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Alisha Elford
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Sara Hamilton
(The Campbell Family Institute for Breast Cancer Research, University Health Network)
- Yi Liang
(Princess Margaret Cancer Centre, University Health Network)
- Juan C. Zúñiga-Pflücker
(University of Toronto
Sunnybrook and Women’s College Health Sciences Centre)
- Housheng Hansen He
(Princess Margaret Cancer Centre, University Health Network
University of Toronto)
- Pamela S. Ohashi
(The Campbell Family Institute for Breast Cancer Research, University Health Network
Princess Margaret Cancer Centre, University Health Network
University of Toronto
University of Toronto)
- Tak W. Mak
(The Campbell Family Institute for Breast Cancer Research, University Health Network
Princess Margaret Cancer Centre, University Health Network
University of Toronto
University of Toronto)
Abstract
T-cell proliferation is regulated by ubiquitination but the underlying molecular mechanism remains obscure. Here we report that Lys-48-linked ubiquitination of the transcription factor KLF4 mediated by the E3 ligase Mule promotes T-cell entry into S phase. Mule is elevated in T cells upon TCR engagement, and Mule deficiency in T cells blocks proliferation because KLF4 accumulates and drives upregulation of its transcriptional targets E2F2 and the cyclin-dependent kinase inhibitors p21 and p27. T-cell-specific Mule knockout (TMKO) mice develop exacerbated experimental autoimmune encephalomyelitis (EAE), show impaired generation of antigen-specific CD8+ T cells with reduced cytokine production, and fail to clear LCMV infections. Thus, Mule-mediated ubiquitination of the novel substrate KLF4 regulates T-cell proliferation, autoimmunity and antiviral immune responses in vivo.
Suggested Citation
Zhenyue Hao & Yi Sheng & Gordon S. Duncan & Wanda Y. Li & Carmen Dominguez & Jennifer Sylvester & Yu-Wen Su & Gloria H.Y. Lin & Bryan E. Snow & Dirk Brenner & Annick You-Ten & Jillian Haight & Satoshi, 2017.
"K48-linked KLF4 ubiquitination by E3 ligase Mule controls T-cell proliferation and cell cycle progression,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14003
DOI: 10.1038/ncomms14003
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14003. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.